Literature DB >> 17086379

Genetically engineered avidins and streptavidins.

O H Laitinen1, V P Hytönen, H R Nordlund, M S Kulomaa.   

Abstract

Chicken avidin and bacterial streptavidin, (strept)avidin, are proteins widely utilized in a number of applications in life science, ranging from purification and labeling techniques to diagnostics, and from targeted drug delivery to nanotechnology. (Strept)avidin-biotin technology relies on the extremely tight and specific affinity between (strept)avidin and biotin (dissociation constant, K(d) approximately 10(-14)-10(-16) M). (Strept)avidins are also exceptionally stable proteins. To study their ligand binding and stability characteristics, the two proteins have been extensively modified both chemically and genetically. There are excellent accounts of this technology and chemically modified (strept)avidins, but no comprehensive reviews exist concerning genetically engineered (strept)avidins. To fill this gap, we here go through the genetically engineered (strept)avidins, summarizing how these constructs were designed and how they have improved our understanding of the structural and functional characteristics of these proteins, and the benefits they have provided for (strept)avidin-biotin technology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17086379     DOI: 10.1007/s00018-006-6288-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  53 in total

1.  Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin.

Authors:  Bijan Zakeri; Jacob O Fierer; Emrah Celik; Emily C Chittock; Ulrich Schwarz-Linek; Vincent T Moy; Mark Howarth
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-24       Impact factor: 11.205

2.  Challenging semi-bootstrapping molecular-replacement strategy reveals intriguing crystal packing of rhizavidin.

Authors:  Amit Meir; Oded Livnah
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-03-26

3.  Internalization of biotinylated compounds into cancer cells is promoted by a molecular Trojan horse based upon core streptavidin and clostridial C2 toxin.

Authors:  Jörg Fahrer; Joschua Funk; Maren Lillich; Holger Barth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-07       Impact factor: 3.000

4.  Multiphoton fabrication of chemically responsive protein hydrogels for microactuation.

Authors:  Bryan Kaehr; Jason B Shear
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-25       Impact factor: 11.205

5.  Designed auto-assembly of nanostreptabodies for rapid tissue-specific targeting in vivo.

Authors:  Philippe Valadon; Bryan Darsow; Tim N Buss; Malgorzata Czarny; Noelle M Griffin; Han N Nguyen; Phil Oh; Per Borgstrom; Adrian Chrastina; Jan E Schnitzer
Journal:  J Biol Chem       Date:  2009-10-22       Impact factor: 5.157

6.  Evolved streptavidin mutants reveal key role of loop residue in high-affinity binding.

Authors:  Maria L B Magalhães; Clarissa Melo Czekster; Rong Guan; Vladimir N Malashkevich; Steven C Almo; Matthew Levy
Journal:  Protein Sci       Date:  2011-05-12       Impact factor: 6.725

7.  Effects of tryptophan residue fluorination on streptavidin stability and biotin-streptavidin interactions via molecular dynamics simulations.

Authors:  Jarosław J Panek; Thomas R Ward; Aneta Jezierska; Marjana Novic
Journal:  J Mol Model       Date:  2008-12-04       Impact factor: 1.810

8.  A streptavidin variant with slower biotin dissociation and increased mechanostability.

Authors:  Claire E Chivers; Estelle Crozat; Calvin Chu; Vincent T Moy; David J Sherratt; Mark Howarth
Journal:  Nat Methods       Date:  2010-04-11       Impact factor: 28.547

9.  Structural and functional characteristics of xenavidin, the first frog avidin from Xenopus tropicalis.

Authors:  Juha A E Määttä; Satu H Helppolainen; Vesa P Hytönen; Mark S Johnson; Markku S Kulomaa; Tomi T Airenne; Henri R Nordlund
Journal:  BMC Struct Biol       Date:  2009-09-29

10.  SnAvi--a new tandem tag for high-affinity protein-complex purification.

Authors:  Ursula Schäffer; Andreas Schlosser; Kristian M Müller; Angelika Schäfer; Nenad Katava; Ralf Baumeister; Ekkehard Schulze
Journal:  Nucleic Acids Res       Date:  2010-01-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.